A natural, barely-absorbed compound from fermented soybeans that works inside the gut. Its best-supported human benefit is improved calcium absorption, greatest in poor absorbers; it also softens the after-meal blood-sugar rise. Immune, antioxidant, gut, and fat effects rest on animal and lab work. Generally well tolerated; long-term value for bone and metabolic health stays uncertain. (Full Review)

Protocol

Typical Intake

100–500 mg/day

Purified supplements; calcium studies used ~60 mg, glucose studies ~440 mg from natto

Timing

With meals

Take with calcium- and carbohydrate-containing meals; actions occur locally in the gut

Dosing Pattern

Split across meals

Benefits are meal-linked, so splitting across main meals is more logical than a single daily dose

Time to effect

Calcium Absorption

Immediate

Occurs within the same meal

Blood Sugar

Same meal

Clearest in the first 15–45 minutes

Bone Benefit

Months

Builds over months of consistent intake

Benefits

Medium: Enhanced calcium absorption

Low: Post-meal blood-sugar moderation; topical skin hydration

Speculative: Immune modulation; antioxidant and gut-lining protection; lipid and metabolic support

Contraindications

Soy allergy (soy-fermented or natto products)

Warfarin or vitamin-K-sensitive anticoagulants (natto source)

Key Interactions

Diabetes medications (insulin, sulfonylureas, metformin)

Binding-sensitive oral drugs (levothyroxine, tetracycline & quinolone antibiotics)

Autoimmune disease or immunosuppressant therapy (high-molecular-weight form)

Risk & Side Effects

Low: Gastrointestinal discomfort; vitamin K interference; soy and natto allergen exposure

Speculative: Mineral and drug binding at high doses; immune activation in autoimmune-prone individuals

Monitoring

Marker	Target	Why
Serum calcium	9.2–10.0 mg/dL	Baseline mineral status
25-OH vitamin D	40–60 ng/mL	Absorption benefit relies on a vitamin-D-dependent pathway
Bone density (DEXA)	T-score above −1.0	Tracks the primary long-term bone goal
Bone turnover (CTX)	Lower half of reference range	Detects bone loss earlier than DEXA
Fasting blood glucose	75–90 mg/dL	Baseline for the metabolic action
HbA1c	Below 5.4%	Longer-term glucose control

Cadence: Calcium, vitamin D & glucose markers at 3 and 6 months, then every 6–12 months; DEXA every 1–2 years

Qualitative Assessment

Digestive comfort and regularity (watching for bloating or loose stools)
Absence of allergic or skin symptoms (especially for soy-sensitive users)
For natto users on anticoagulants, stability of clotting control between checks
General sense of dietary tolerability and adherence

Poly-γ-Glutamic Acid for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment